Lipum

Umea, Sweden Founded: 2010 • Age: 16 yrs
Developer of antibody to treat juvenile idiopathic arthritis
Request Access

About Lipum

Lipum is a company based in Umea (Sweden) founded in 2010 by Lennart Lundberg, Olle Hernell, and Susanne Lindquist.. Lipum has raised $2.99 million across 7 funding rounds from investors including European Union, Almi and EIC Fund. Lipum offers products and services including SOL-116. Lipum operates in a competitive market with competitors including BeiGene, Moderna, Forge Biologics, Incyte and ALX Oncology, among others.

  • Headquarter Umea, Sweden
  • Founders Lennart Lundberg, Olle Hernell, Susanne Lindquist
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lipum Ab (Publ)
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.99 M (USD)

    in 7 rounds

  • Latest Funding Round
    $59.81 K (USD), Grant

    Nov 30, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lipum

Lipum offers a comprehensive portfolio of products and services, including SOL-116. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Humanized antibody for treating rheumatoid arthritis and other inflammations.

People of Lipum
Headcount 1-10
Employee Profiles 4
Board Members and Advisors 5
Employee Profiles
People
Einar Pontén
CEO
People
Pernilla Abrahamsson
COO
People
Marina Norberg
CFO
People
Susanne Lindquist
Co-Founder & Head, Research

Unlock access to complete

Board Members and Advisors
people
Kristian Sandberg
Board Member
people
Olle Hernell
Board Member
people
Ulf Björklund
Chairman
people
Ingemar Kihlström
Board Member

Unlock access to complete

Funding Insights of Lipum

Lipum has successfully raised a total of $2.99M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $59.81 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Grant — $59,811
  • First Round

    (24 Aug 2016)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2020 Amount Grant - Lipum Valuation

investors

Mar, 2019 Amount Series A - Lipum Valuation Almi
Mar, 2019 Amount Grant - Lipum Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lipum

Lipum has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Almi and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Investments are provided by Almi in seed to growth-stage startups.
Founded Year Domain Location
Multiple sectors are invested in by corporate-backed Almi Invest.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lipum

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lipum

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lipum Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lipum

Lipum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Forge Biologics, Incyte and ALX Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Gene therapies for rare diseases are developed to treat patients.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
ALX Oncology is focused on advancing cancer treatment therapies.
domain founded_year HQ Location
Therapeutic antibodies for cancer and other diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lipum

Frequently Asked Questions about Lipum

When was Lipum founded?

Lipum was founded in 2010 and raised its 1st funding round 6 years after it was founded.

Where is Lipum located?

Lipum is headquartered in Umea, Sweden.

Who is the current CEO of Lipum?

Einar Ponten is the current CEO of Lipum.

Is Lipum a funded company?

Lipum is a funded company, having raised a total of $2.99M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.69M, raised on Aug 24, 2016.

What does Lipum do?

Lipum has developed an antibody-based drug to treat juvenile idiopathic arthritis (JIA). The company has developed a monoclonal antibody (SOL-116) to target and block the function of protein denoted bile salt-stimulated lipase (BSSL) to treat chronic inflammatory diseases such as juvenile idiopathic arthritis.

Who are the top competitors of Lipum?

Lipum's top competitors include Moderna, BeiGene and Forge Biologics.

What products or services does Lipum offer?

Lipum offers SOL-116.

Who are Lipum's investors?

Lipum has 4 investors. Key investors include European Union, Almi, EIC Fund, and Almi Invest.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available